Trial0

Clinical trial · NCT07424365 · RECRUITING · NA

Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations

Sponsor: University of Colorado, Denver

We save this real registry record and notify you if its published status changes. Create an account to add profile details that improve future matching.

Summary

This study plans to learn more about how stimulating the vagus nerve through gentle electrical stimulation applied to the ear can affect decision-making, problem-solving, and other thinking abilities. This process, called transcutaneous auricular vagus nerve stimulation (taVNS), could help improve brain function in both healthy individuals and people with Parkinson's disease (PD).

Interventions

  • transcutaneous auricular vagus nerve stimulation · DEVICE

    Electrical stimulation targeting the auricular branch of the vagus nerve

  • sham stimulation · DEVICE

    Sham stimulation of the outer ear that does not target the vagus nerve

Published eligibility criteria

Verbatim from the registry. Only the site can decide how these apply to a specific patient.

Inclusion Criteria:

1. Individuals aged 18-65.
2. Ability to sign informed consent.
3. Ability to follow written and verbal instructions.
4. For the PD group, a clinical diagnosis of Parkinson's disease without severe motor or cognitive impairments.

Exclusion Criteria:

1. Current uncontrolled and/or clinically significant medical condition.
2. Abnormal ear anatomy or active ear infection.
3. Electronic medical implants, such as pacemakers, cochlear prosthesis, neuro-stimulators.
4. Uncorrected visual impairments that would interfere with task performance.

(6) Other significant diseases or disorders that might impair study participation.

Sites (1)

  • Clinical Translational Research Center at CU Anschutz, Aurora, Colorado · RECRUITING

Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2026-02-20.